A Pilot Study on Cannabidiol (CBD) and Eccentric Exercise: Impact on Inflammation, Performance, and Pain

Area of Science:

• Exercise Physiology
• Nutritional Science
• Pharmacology

Background:

• Cannabidiol (CBD), a non-psychoactive cannabinoid, is increasingly used for various conditions, including chronic pain and seizures.
• Animal studies suggest CBD may reduce inflammation following strenuous exercise, but human data is limited.
• Eccentric exercise protocols can induce muscle damage and inflammation, making them a relevant model for testing anti-inflammatory agents.

Purpose of the Study:

• To investigate the effects of two doses of CBD oil on inflammation (IL-6), performance, and pain after an eccentric loading protocol in humans.
• To evaluate the potential of CBD as an anti-inflammatory and recovery aid following exercise-induced muscle stress.

Main Methods:

• A randomized, counterbalanced, placebo-controlled design involving 4 participants.
• Participants underwent an eccentric bicep curl protocol and received either placebo, low-dose (2mg/kg), or high-dose (10mg/kg) CBD oil.
• Blood samples were collected pre-exercise and at 24, 48, and 72 hours post-exercise to measure IL-6 levels; strength and pain were also assessed.

Main Results:

• No statistically significant differences were found in IL-6 levels, handgrip strength, or bicep curl strength between CBD and placebo conditions.
• Pain levels showed a significant difference across time but not between conditions.
• A trend suggested lower IL-6 levels at 48 and 72 hours post-exercise in the CBD groups compared to placebo, though not statistically significant.

Conclusions:

• This study found no significant impact of CBD on inflammation, performance, or pain following eccentric exercise in humans.
• The observed trend of reduced IL-6 in CBD groups warrants further investigation with larger sample sizes.
• Future research should consider larger sample sizes and different exercise protocols to better assess CBD's potential benefits.